Sign In
Buy BMXMF
$83.31
+0 (+0%)
At Close: Jun 03, 2026
bioMérieux S.A. (BMXXY) Q1 2026 Sales/Trading Call Transcript
11:31am, Thursday, 23'rd Apr 2026
bioMérieux S.A. (BMXXY) Q1 2026 Sales/Trading Call Transcript
Analyzing HealthEquity (NASDAQ:HQY) and bioMerieux (OTCMKTS:BMXMF)
03:21am, Tuesday, 21'st Apr 2026
HealthEquity (NASDAQ: HQY - Get Free Report) and bioMerieux (OTCMKTS:BMXMF - Get Free Report) are both medical companies, but which is the better business? We will contrast the two companies based on
bioMerieux (OTCMKTS:BMXMF) Shares Gap Up – Time to Buy?
03:48am, Sunday, 01'st Mar 2026
Shares of bioMerieux (OTCMKTS:BMXMF - Get Free Report) gapped up prior to trading on Friday. The stock had previously closed at $109.61, but opened at $115.00. bioMerieux shares last traded at $115.00
bioMérieux S.A. (BMXXY) Q4 2025 Earnings Call Transcript
03:27pm, Friday, 27'th Feb 2026
bioMérieux S.A. (BMXXY) Q4 2025 Earnings Call Transcript
bioMerieux (OTCMKTS:BMXMF) Sees Unusually-High Trading Volume – Time to Buy?
03:26am, Sunday, 22'nd Feb 2026
bioMerieux (OTCMKTS:BMXMF - Get Free Report) saw unusually-high trading volume on Friday. Approximately 137 shares were traded during mid-day trading, an increase of 37% from the previous session's vo
bioMérieux S.A. (BMXXY) Analyst/Investor Day Transcript
02:36pm, Tuesday, 04'th Nov 2025
bioMérieux S.A. (OTCPK:BMXXY) Analyst/Investor Day November 4, 2025 8:30 AM EST Company Participants Aymeric Fichet Pierre Boulud - Chief Executive Officer Guillaume Bouhours - Executive VP of Purcha
bioMérieux S.A. (BMXMF) Q4 2024 Earnings Call Transcript
03:53pm, Friday, 07'th Mar 2025
bioMérieux S.A. (OTCPK:BMXMF) Q4 2024 Results Conference Call March 7, 2025 8:00 AM ET Company Participants Aymeric Fichet - Investor Relations Pierre Boulud - Chief Executive Officer Guillaume Bouho
bioMérieux S.A. (BMXMF) Q2 2024 Earnings Call Transcript
12:44pm, Monday, 09'th Sep 2024
bioMérieux S.A. (OTCPK:BMXMF) Q2 2024 Results Conference Call September 5, 2024 8:00 AM ET Company Participants Aymeric Fichet - IR Pierre Boulud - Chief Executive Officer Guillaume Bouhours - CFO Co
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript
03:51pm, Wednesday, 02'nd Mar 2022
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript
12:47pm, Thursday, 21'st Oct 2021
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript
bioMérieux: Pioneering In Vitro Diagnostics
09:47am, Thursday, 19'th Aug 2021
bioMérieux: Pioneering In Vitro Diagnostics
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript
09:26am, Sunday, 28'th Feb 2021
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript
4 Top Medical Services Stocks to Beat COVID-19 Resurgence Crisis
12:47pm, Thursday, 17'th Dec 2020
The COVID-19 crisis has drastically transformed the fortune of the medical services industry. The industry has been witnessingsignificant demand for telemedicine-focused online medical services.
bioMerieux price target raised to EUR 118 from EUR 78 at Berenberg BMXMF
07:20am, Thursday, 30'th Apr 2020
bioMerieux price target raised to EUR 118 from EUR 78 at Berenberg Berenberg BMXMF
